Hepatitis D, Chronic - 20 Studies Found Active, not recruiting : A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. : Hepatitis D, Chronic : 2010-03-16 : Drug: peginterferon alfa-2a [Pegasys] Active, not recruiting : Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D : Hepatitis D, Chronic : 2017-03-26 : Drug: Pegylated interferon alfa Completed : A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) : Hepatitis D, Chronic : 2016-04-05 : Drug: Pegylated Interferon (PEG-IFN) alfa-2a Participants received pegylated interferon (PEG-IFN) alfa-2 Completed : A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) : Hepatitis D, Chronic : 2016-04-01 : Drug: Peginterferon alfa-2a Pe Terminated : An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) : Hepatitis D, Chronic : 2013-05-02 Recruiting : Ezetimibe for Patients With Chronic Hepatitis D : Chronic Hepatitis D : 2017-03-28 : Drug: Ezetimibe Ezetimibe 20 mg oral daily Recruiting : A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection : Hepatitis D, Chronic : 2016-05-05 : Drug: Lambda Not yet recruiting : A Study of Lonafarnib With or Without Ritonavir in Patients With HDV : Chronic Delta Hepatitis : 2016-11-15 : Drug: Lonafarnib antiviral far Completed : Titrating-Dose of Lonafarnib in Combination With Ritonavir : Chronic Delta Hepatitis : 2015-08-13 : Drug: lonafarnib antiviral far Active, not recruiting : A Long Term Follow-up Study of Patients From the REP 301 Protocol : Hepatitis B, Chronic Hepatitis D, Chronic : 2016-08-16 Next >>>